A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
A recent study examined how prior SARS-CoV-2 vaccination influences innate and adaptive immune responses in breakthrough infections, revealing distinct immune activation patterns.
This respiratory health update covers rising influenza deaths, the spread of new SARS-CoV-2 variants, shifting reinfection patterns, and cardiovascular risks in children
In this respiratory diseases roundup, researchers examine COVID-19 protection, hospitalization rates, long COVID predictors, and rare disease mortality risks.
A randomized trial comparing influenza vaccines over two seasons found that recombinant vaccines showed stronger immune responses to A/H3N2 strains compared with egg-based and cell culture-based vaccines.
...
In this respiratory disease roundup, experts examine the rising cases of human metapneumovirus in China, new research on COVID-19’s long-term effects on kidney function, the effectiveness of...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
This respiratory health roundup highlights the emerging links between lung and brain health in long COVID, rising avian flu cases in humans and animals, additional insights into the lasting health impacts...
A new study finds similar in-hospital mortality rates for health care-associated COVID-19 and influenza, highlighting the ongoing clinical burden of both diseases in hospitalized patients.
